24 Results

People

  1. Giralt
    Giralt
  2. Aghajanian
    Aghajanian
  3. Capanu
    Capanu
  4. Chou
    Chou
  5. Dunn
    Dunn
  6. Ho
    Ho
  7. Ilson
    Ilson
  8. Janjigian
    Janjigian
  9. Ku
    Ku
  10. Lee
    Lee

Groups

  1. Department of Medicine (17)
  2. Solid Tumor Oncology Division (10)
  3. Hematologic Malignancies, Division of (8)
  4. Center for Hematologic Malignancies (6)
  5. Survivorship Research (6)
  6. Bone Marrow Transplant (5)
  7. Center for Pancreatic Cancer Research (5)
  8. GSK Faculty (5)
  9. Radiology, Department of (5)
  10. Weinberg Fellows (5)
  1. "oral mucositis"
Formats
  1. Journal Article (20)
  2. Review (4)
Groups
  1. Department of Medicine (17)
  2. Solid Tumor Oncology Division (10)
  3. Hematologic Malignancies, Division of (8)
  4. Center for Hematologic Malignancies (6)
  5. Survivorship Research (6)
  6. Bone Marrow Transplant (5)

More Groups

People
  1. Sergio Giralt (3)
  2. Alan Ho (2)
  3. Carol Aghajanian (2)
  4. David Ilson (2)
  5. David Pfister (2)
  6. David Solit (2)

More People

Years
  1. 2025 (2)
  2. 2024 (2)
  3. 2023 (4)
  4. 2022 (3)
  5. 2021 (1)
  6. 2020 (3)

More Years

Publications
  1. CA - A Cancer Journal for Clinicians (2)
  2. Gynecologic Oncology (2)
  3. Journal of Clinical Oncology (2)
  4. Lancet Oncology (2)
  5. Supportive Care in Cancer (2)
  6. Blood Reviews (1)

More Publications

Publishers
  1. Elsevier Inc. (6)
  2. Elsevier Science, Inc. (3)
  3. American Society of Clinical Oncology (2)
  4. Springer (2)
  5. Springer Verlag (2)
  6. Churchill Livingstone (1)

More Publishers

Results (24)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 study of the combination of BH3-mimetic, navitoclax, and mTORC1/2 inhibitor, vistusertib, in patients with advanced solid tumors
    Journal Article

    Scott, S. C.; Farago, A.; Lai, W. V.; Zahurak, M.; Rudek, M. A.; Murray, J.; Carducci, M. A.; Uziel, T.; Takebe, N.; Gore, S. D.; more...
    Cancer Chemotherapy and Pharmacology (2025)

    Fulltext@MSK | Save
  • Effectiveness and safety of combined treatment with herbal medicines and palliative chemotherapy for advanced gastric cancer: A systematic review, and meta-analysis
    Review

    Kim, D. H.; Kim, S. D.; Jun, H. J.; Kwag, E. B.; Shin, S. W.; Yoo, H. S.; Park, S. J.
    Integrative Medicine Research (2025)

    Fulltext@MSK | Save
  • Optimizing high dose melphalan
    Review

    Shah, G.; Giralt, S.; Dahi, P.
    Blood Reviews (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)
    Journal Article

    Lumish, M.; Chui, M. H.; Zhou, Q.; Iasonos, A.; Sarasohn, D.; Cohen, S.; Friedman, C.; Grisham, R.; Konner, J.; Kyi, C.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of regorafenib in combination with immune checkpoint inhibitor therapy as second-line and third-line regimen for patients with advanced hepatocellular carcinoma: A retrospective study
    Journal Article

    Zhao, J.; Guo, Y.; Feng, T.; Rong, D.; Kong, X.; Huang, T.; Lopez-Lopez, V.; Yarmohammadi, H.; Sakamoto, Y.; Zhu, D.; more...
    Journal of Gastrointestinal Oncology (2023)

    Fulltext@MSK | Save
  • First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: A single-arm, single-centre, phase 2 trial
    Journal Article

    Cytryn, S. L.; Moy, R. H.; Cowzer, D.; Shah, R. H.; Chou, J. F.; Joshi, S. S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Randomized phase III trial of ganitumab with interval-compressed chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma: A report from the Children's Oncology Group
    Journal Article

    DuBois, S. G.; Krailo, M. D.; Glade-Bender, J.; Buxton, A.; Laack, N.; Randall, R. L.; Chen, H. X.; Seibel, N. L.; Boron, M.; Terezakis, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus-associated oropharyngeal cancer
    Review

    Kang, J. J.; Yu, Y.; Chen, L.; Zakeri, K.; Gelblum, D. Y.; McBride, S. M.; Riaz, N.; Tsai, C. J.; Kriplani, A.; Hung, T. K. W.; more...
    CA - A Cancer Journal for Clinicians (2023)

    Fulltext@MSK | Save
  • Oncologic emergencies and urgencies: A comprehensive review
    Review

    Gould Rothberg, B. E.; Quest, T. E.; Yeung, S. C. J.; Pelosof, L. C.; Gerber, D. E.; Seltzer, J. A.; Bischof, J. J.; Thomas, C. R. Jr; Akhter, N.; Mamtani, M.; more...
    CA - A Cancer Journal for Clinicians (2022)

    Fulltext@MSK | Save
  • Triplet therapy, transplantation, and maintenance until progression in myeloma
    Journal Article

    Richardson, P. G.; Jacobus, S. J.; Weller, E. A.; Hassoun, H.; Lonial, S.; Raje, N. S.; Medvedova, E.; McCarthy, P. L.; Libby, E. N.; Voorhees, P. M.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save